StockData
Blackstone Inc. logo

Blackstone Inc.

BXNYSEInvestment AdviceFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 11/307% above fair value
$120.14+1.63 (+1.38%)

Close on Nov 2, 2026Market cap $90.18BP/E 26.9Yield 3.90%

Blackstone Life Sciences (BXLS) — NAPR by Quarter

Life Sciences (BXLS) — NAPR ($M)

QuarterlyAnnual

Blackstone Life Sciences (BXLS) — NAPR: $270M in Q3 2026, up 12.5% from a year earlier. That is the highest of the 26 quarters on record here.

Latest, Q3 2026
270
Period ended Sep 30, 2026
Change on a year earlier
+12.5%
240 in Q3 2025
History
26 quarters
Since Q2 2020
Sources
22
Documents cited below

Where the Q3 2026 figure comes from

Source: Blackstone Inc. Form 8-K (Earnings Release EX-99.1) (2026-10-22, filed 2026-10-22) ↗

Reported in BX Form 8-K EX-99.1 (NAPR, Deconsolidated Balance Sheet & Share Summary).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLife Sciences (BXLS) — NAPR ($M)Year on yearSource
Q3 2026Sep 30, 2026270+12.5%Blackstone Inc. Form 8-K (Earnings Release EX-99.1) (2026-10-22, filed 2026-10-22) ↗
Q2 2026Jun 30, 2026253+5.9%Blackstone Inc. Form 8-K (Earnings Release EX-99.1) (2026-10-22, filed 2026-10-22) ↗
Q1 2026Mar 31, 2026228+6.5%Blackstone Inc. Form 8-K (Earnings Release EX-99.1) (2026-07-23, filed 2026-07-23) ↗
Q4 2025Dec 31, 2025216+9.6%Blackstone Inc. Form 8-K (Earnings Release EX-99.1) (2026-04-23, filed 2026-04-23) ↗
Q3 2025Sep 30, 2025240+65.5%Blackstone Inc. Form 8-K (Earnings Release EX-99.1) (2026-10-22, filed 2026-10-22) ↗
Q2 2025Jun 30, 2025239+91.2%Blackstone Inc. Form 8-K (Earnings Release EX-99.1) (2026-07-23, filed 2026-07-23) ↗
Q1 2025Mar 31, 2025214+151.8%Blackstone Inc. Form 8-K (Earnings Release EX-99.1) (2026-04-23, filed 2026-04-23) ↗
Q4 2024Dec 31, 2024197+140.2%Blackstone Inc. Form 8-K (Earnings Release EX-99.1) (2026-01-29, filed 2026-01-29) ↗
Q3 2024Sep 30, 2024145+133.9%Blackstone Inc. Form 8-K (Earnings Release EX-99.1) (2025-10-23, filed 2025-10-23) ↗
Q2 2024Jun 30, 2024125+420.8%Blackstone Inc. Form 8-K (Earnings Release EX-99.1) (2025-07-24, filed 2025-07-24) ↗
Q1 2024Mar 31, 202485+193.1%Blackstone Inc. Form 8-K (Earnings Release EX-99.1) (2025-04-17, filed 2025-04-17) ↗
Q4 2023Dec 31, 202382+228.0%Blackstone Inc. Form 8-K (Earnings Release EX-99.1) (2025-01-30, filed 2025-01-30) ↗
Q3 2023Sep 30, 202362+138.5%Blackstone Inc. Form 8-K (Earnings Release EX-99.1) (2024-10-17, filed 2024-10-17) ↗
Q2 2023Jun 30, 2023240.0%Blackstone Inc. Form 8-K (Earnings Release EX-99.1) (2024-07-18, filed 2024-07-18) ↗
Q1 2023Mar 31, 202329+31.8%Blackstone Inc. Form 8-K (Earnings Release EX-99.1) (2024-04-18, filed 2024-04-18) ↗
Q4 2022Dec 31, 202225+19.0%Blackstone Inc. Form 8-K (Earnings Release EX-99.1) (2024-01-25, filed 2024-01-25) ↗

Cite this data

StockData. (2026). Blackstone Life Sciences (BXLS) — NAPR ($M), quarterly Q2 2020–Q3 2026 [Data set]. Compiled from Blackstone SEC filings and investor materials. https://stockdatahq.com/stocks/bx/kpis/napr-bxls-row

See every metric in the Blackstone KPI table. Data updated Nov 1, 2026.